Description
Rapid, in-house EGFR testing for fast treatment decisions directly impacting NSCLC patient outcomes
IdyllaTM EGFR Mutation Test (CE-IVD)
Within 150 minutes and with less than 2 minutes hands-on time, the fully automated IdyllaTM EGFR Mutation Test covers 51 mutations in exons 18–21 in a single cartridge using only 1 FFPE tissue section from metastatic NSCLC showing a high concordance of >95% compared with reference methods.
Specimen requirements
One of the biggest challenges in oncology biomarker testing is the ability to obtain samples of sufficient size and quality. With the IdyllaTM System only a minimal amount of sample is needed
- 1x 5 μm FFPE tissue section
- Neoplastic cells ≥10% – if less, macrodissection is required
Avis
Il n’y a pas encore d’avis.